SRSF10 and neoplasm: Simultaneously, a global screening of the potential associations between the expression levels of each of the splicing factors measured with the most relevant clinical parameters of patients provided an informative snapshot (Additional file 2: Figure S2), which allowed us to select another interesting component of the splicing machinery, SRSF10, that was also overexpressed in tumor tissue.